X0206 3 2018-11-05 0 0001731831 Eidos Therapeutics, Inc. EIDX 0001758363 Turtle Cameron EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 0 1 0 0 Chief Business Officer Common Stock 107305 D Stock Option (right to buy) 17.00 2028-06-21 Common Stock 23920 D Stock Option (right to buy) 13.20 2028-11-05 Common Stock 105000 D The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 23,920 stock options (the "Grant") on June 22, 2018. The shares subject to the Grant shall vest and become exercisable in 48 equal monthly installments following June 18, 2018, subject to the Reporting Person's continued service to the Issuer through each vesting date. The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 105,000 stock options (the "Grant") on November 5, 2018. The shares subject to the Grant shall vest and become exercisable as follows: one quarter of the shares shall vest on November 5, 2019 and the remaining unvested shares shall vest ratably over the following 36 months, subject to the Reporting Person's continued service to the Issuer through each vesting date. Exhibit 24.1 - Power of Attorney /s/ Franco Valle, Attorney-in-Fact 2018-11-07